Zantac / Ranitidine (NDMA Cancer) Lawsuit in Kansas

Preparing your case review…
Written By
People's Justice Legal Research Team

Statute of Limitations

Kansas imposes a 2-year statute of limitations for personal injury claims (K.S.A. § 60-513). The discovery rule applies in pharmaceutical injury litigation. Kansas courts apply Daubert reliability standards for expert testimony under K.S.A. § 60-456. Claimants with 2024 or later diagnoses have an active filing window; earlier diagnoses require discovery rule analysis.

2 years from date of cancer diagnosis discovery (Daubert expert standard)

Kansas Data

Exposure in Kansas

Source: U.S. Census Bureau 2024

Source: Delaware litigation tracking 2025

Medical Resources

Clinics & Specialists in Kansas

University of Kansas Cancer Center

Via Christi Cancer Center

Back to Zantac / Ranitidine (NDMA Cancer) Lawsuit Overview